Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
AUR-108 by Les Laboratoires Servier for Leukemia: Likelihood of Approval
AUR-108 is under clinical development by Les Laboratoires Servier and currently in Phase I for Leukemia. According to GlobalData, Phase...